Elementis reported increased operating profits driven by cost-cutting and the $40M sale of its pharma business to ABF, projecting 2026 as a year of progress.
chemweek · 2026-03-05 22:10
Elementis has acquired Alchemy Ingredients, a UK developer of sustainable rheology modifiers for personal care, to expand its product portfolio.
chemweek · 2025-11-27 17:59
Elementis anticipates full-year earnings will meet estimates, citing stable Q3 revenue and improved operating profit, alongside a goal of $12 million in cost savings by year-end.
chemweek · 2025-10-29 18:56